National Institute of Biology creates gene therapy spin-off
Ljubljana, 21 April - The National Institute of Biology (NIB) has licenced its gene therapy know-how and technology to a spin-off called Niba Labs, which will develop and commercialise technologies for the characterisation and quantification of therapeutic viruses used in gene therapy.
The rest of this news item is available to subscribers.
The news item consists of 657 characters (without spaces) or 126 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.